Skip to main content

Want a detailed portfolio tracker?

Impact BioMedical (IBO) P/E (2024 - 2026)

Impact BioMedical (IBO) P/E from Sep 16, 2024 to Jul 21, 2026. The TTM Impact BioMedical (IBO) P/E is -21.18. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Impact BioMedical (IBO)

YearP/EChange
2026-21.18-310.49%
202510.06-111.62%
2024-86.63N/A

Comparison Impact BioMedical (IBO) P/E with competitors

Impact BioMedical (IBO) P/E is -21.18.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.01%
NBYStablecoin Development Corp0.00-100.02%
ENLVEnlivex Ltd0.07-100.35%
FGENFibroGen Inc0.24-101.13%
CHRSCoherus Biosciences Inc0.85-104.01%
FBIOFortress Biotech Inc0.95-104.48%
ORMPOramed Pharmaceuticals Inc1.50-107.10%
AGENAgenus Inc3.01-114.21%
INVAInnoviva Inc3.15-114.89%
VXRTVaxart Inc3.55-116.76%
CRMDCorMedix Inc3.63-117.13%
CVACCureVac N.V.4.45-120.99%
GLPGGalapagos NV4.86-122.94%
SRPTSarepta Therapeutics Inc4.88-123.05%
ABEOAbeona Therapeutics Inc5.39-125.43%
ABUSArbutus Biopharma Corp5.60-126.41%
ZVRAZevra Therapeutics Inc5.89-127.79%
SPROSpero Therapeutics Inc6.23-129.40%
CGENCompugen Ltd6.31-129.81%
RIGLRigel Pharmaceuticals6.87-132.44%
SLXNSilexion Therapeutics Corp7.30-134.44%
OMEROmeros Corporation9.26-143.71%
AUPHAurinia Pharmaceuticals Inc9.58-145.25%
PLXProtalix BioTherapeutics Inc10.89-151.41%
ACADAcadia Pharmaceuticals Inc11.73-155.37%
TBPHTheravance Biopharma Inc12.26-157.88%
ADMAAdma Biologics Inc12.42-158.62%
HRMYHarmony Biosciences Holdings Inc13.82-165.24%
SABSSAB Biotherapeutics Inc14.14-166.73%
NAGENiagen Bioscience Inc14.82-169.95%
INCYIncyte Corp15.82-174.69%
REGNRegeneron Pharmaceuticals Inc15.86-174.85%
PBYIPuma Biotechnology Inc17.32-181.74%
CPRXCatalyst Pharmaceuticals Inc17.44-182.32%
EXELExelixis Inc17.54-182.79%
TGTXTG Therapeutics Inc18.97-189.53%
MDXGMimedx Group Inc20.55-197.02%
XOMAXOMA Royalty Corp22.87-207.99%
ARGXArgen X SE24.30-214.70%
CTMXCytomX Therapeutics Inc24.82-217.17%
XOMAOXOMA Royalty Corp25.34-219.65%
HALOHalozyme Therapeutics Inc25.62-220.96%
XOMAPXOMA Royalty Corp25.67-221.18%
VRTXVertex Pharmaceuticals Inc27.99-232.16%
RPRXRoyalty Pharma plc - Class A28.69-235.43%
SLNOSoleno Therapeutics Inc29.02-236.97%
ASNDAscendis Pharma A/S30.09-242.03%
LGNDLigand Pharmaceuticals Inc - Class B37.91-278.97%
APLSApellis Pharmaceuticals Inc39.02-284.21%
BMRNBiomarin Pharmaceutical Inc42.21-299.27%
KRYSKrystal Biotech Inc45.34-314.06%
ONCBeiGene Ltd69.54-428.28%
PHARPharming Group N.V.75.03-454.18%
TECHBio-Techne Corp101.96-581.32%
VCELVericel Corp109.92-618.91%
ALNYAlnylam Pharmaceuticals Inc117.96-656.88%
GMABGenmab140.29-762.28%
TLXTelix Pharmaceuticals Ltd162.15-865.48%
CORTCorcept Therapeutics Inc212.86-1104.85%